Inhalatorial sedation in patient with SAH versus conventional intravenus sedation - GAS
- Conditions
- sub-arachnoid haemorrage
- Registration Number
- EUCTR2008-008143-24-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA SAN GERARDO DI MONZA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosis of aSAH - indication to DVE positioning - clinical indication to sedation and assisted ventilation - indication to ICP and CBF monitoring - age >18
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- documented cranical hypertension (ICP>18) not controller by liquor drainage - age<18.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Evaluate the Cerebral Blood flow variation associated to isoflurano sedation versus propofol sedation;Secondary Objective: nd;Primary end point(s): Evaluate the Cerebral Blood flow variation associated to isoflurano sedation versus propofol sedation
- Secondary Outcome Measures
Name Time Method